Under the agreement, Diagnostic Products, of
Compugen, of Tel Aviv, is entitled to milestone payments as well as royalties on the sales of any diagnostic products. Compugen also has the right to develop any biomarkers for therapeutic purposes.
Under the agreement, Diagnostic Products, of
Compugen, of Tel Aviv, is entitled to milestone payments as well as royalties on the sales of any diagnostic products. Compugen also has the right to develop any biomarkers for therapeutic purposes.